Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
The LUCINDA Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 16, 2020
Indications for Use of CD34 Selection Column (CliniMACS-Miltenyi Biotec)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 12, 2020
A Multi-center Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adults Patients with Hematologic Malignancies and Other Indications
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 12, 2020
Protocol for A Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 12, 2020
National Marrow Donor Program (NMDP) and Center for International Blood and Marrow Transplant Research (CIBMTR) – Research Database for Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 12, 2020
Advancing Liver Therapeutic Approaches (ALTA). The ALTA Consortium Study Group for the Management of Portal Hypertension – A 5-year Longitudinal Observation Study of Patients with Cirrhosis Undergoing TIPS Placement
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 10, 2020
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
Study Status:
Open to Enrollment
Primary Investigator:
Date:
September 15, 2020
Phase I/II Dose-Escalation Study of Fractionated and Multiple Dose 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 8, 2020
Single-Arm Phase II Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
January 13, 2021
A Pilot Study of Rimegepant in Moderate Plaque-type Psoriasis
Study Status:
Open to Enrollment
Primary Investigator:
Date:
January 15, 2021
« first
‹ previous
1
2
3
4
(current)
5
6
7
8
9
…
next ›
last »